Liesbeth Reneman - Publications

Affiliations: 
Academic Medical Center Amsterdam, Amsterdam, Netherlands 

152 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Belov V, Erwin-Grabner T, Aghajani M, Aleman A, Amod AR, Basgoze Z, Benedetti F, Besteher B, Bülow R, Ching CRK, Connolly CG, Cullen K, Davey CG, Dima D, Dols A, ... ... Reneman L, et al. Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures. Scientific Reports. 14: 1084. PMID 38212349 DOI: 10.1038/s41598-023-47934-8  0.665
2023 Boucherie DE, Reneman L, Booij J, Martins D, Dipasquale O, Schrantee A. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study. Journal of Psychopharmacology (Oxford, England). 2698811231211154. PMID 37947344 DOI: 10.1177/02698811231211154  0.687
2023 Boucherie DE, Reneman L, Ruhé HG, Schrantee A. Neurometabolite changes in response to antidepressant medication: A systematic review of H-MRS findings. Neuroimage. Clinical. 40: 103517. PMID 37812859 DOI: 10.1016/j.nicl.2023.103517  0.626
2023 Breedt LC, Santos FAN, Hillebrand A, Reneman L, van Rootselaar AF, Schoonheim MM, Stam CJ, Ticheler A, Tijms BM, Veltman DJ, Vriend C, Wagenmakers MJ, van Wingen GA, Geurts JJG, Schrantee A, et al. Multimodal multilayer network centrality relates to executive functioning. Network Neuroscience (Cambridge, Mass.). 7: 299-321. PMID 37339322 DOI: 10.1162/netn_a_00284  0.654
2022 van Genderen JG, Chia C, Van den Hof M, Mutsaerts HJMM, Reneman L, Pajkrt D, Schrantee A. Brain Differences in Adolescents Living With Perinatally Acquired HIV Compared to Adoption Status Match Controls: A Cross-Sectional Study. Neurology. PMID 35940898 DOI: 10.1212/WNL.0000000000200946  0.62
2022 Kaiser A, Broeder C, Cohen JR, Douw L, Reneman L, Schrantee A. Effects of a single-dose methylphenidate challenge on resting-state functional connectivity in stimulant-treatment naive children and adults with ADHD. Human Brain Mapping. PMID 35781371 DOI: 10.1002/hbm.25981  0.81
2022 Batelaan NM, Seldenrijk A, van den Heuvel OA, van Balkom AJLM, Kaiser A, Reneman L, Tan HL. Anxiety, Mental Stress, and Sudden Cardiac Arrest: Epidemiology, Possible Mechanisms and Future Research. Frontiers in Psychiatry. 12: 813518. PMID 35185641 DOI: 10.3389/fpsyt.2021.813518  0.721
2022 Kaiser A, Reneman L, Solleveld MM, Coolen BF, Scherder EJA, Knutsson L, Bjørnerud A, van Osch MJP, Wijnen JP, Lucassen PJ, Schrantee A. A Randomized Controlled Trial on the Effects of a 12-Week High- vs. Low-Intensity Exercise Intervention on Hippocampal Structure and Function in Healthy, Young Adults. Frontiers in Psychiatry. 12: 780095. PMID 35126199 DOI: 10.3389/fpsyt.2021.780095  0.777
2021 de Ruiter MB, Reneman L, Kieffer JM, Oldenburg HSA, Schagen SB. Brain White Matter Microstructure as a Risk Factor for Cognitive Decline After Chemotherapy for Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 39: 3908-3917. PMID 34591652 DOI: 10.1200/JCO.21.00627  0.74
2021 Kaiser A, Reneman L, Lucassen PJ, de Vries TJ, Schrantee A, Kaag AM. Targeting working memory to modify emotional reactivity in adult attention deficit hyperactivity disorder: a functional magnetic resonance imaging study. Brain Imaging and Behavior. PMID 34524649 DOI: 10.1007/s11682-021-00532-6  0.79
2021 Campos AI, Thompson PM, Veltman DJ, Pozzi E, van Veltzen LS, Jahanshad N, Adams MJ, Baune BT, Berger K, Brosch K, Bülow R, Connolly CG, Dannlowski U, Davey CG, de Zubicaray GI, ... ... Reneman L, et al. Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts. Biological Psychiatry. PMID 34172278 DOI: 10.1016/j.biopsych.2021.03.015  0.654
2021 Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, ... ... Reneman L, et al. Correction: Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders. Molecular Psychiatry. PMID 34158622 DOI: 10.1038/s41380-021-01191-1  0.658
2021 Reneman L, van der Pluijm M, Schrantee A, van de Giessen E. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. European Journal of Radiology. 140: 109752. PMID 34004428 DOI: 10.1016/j.ejrad.2021.109752  0.624
2021 Tahmasian M, Aleman A, Andreassen OA, Arab Z, Baillet M, Benedetti F, Bresser T, Bright J, Chee MWL, Chylinski D, Cheng W, Deantoni M, Dresler M, Eickhoff SB, Eickhoff CR, ... ... Reneman L, et al. ENIGMA-Sleep: Challenges, opportunities, and the road map. Journal of Sleep Research. e13347. PMID 33913199 DOI: 10.1111/jsr.13347  0.551
2021 Postema MC, Hoogman M, Ambrosino S, Asherson P, Banaschewski T, Bandeira CE, Baranov A, Bau CHD, Baumeister S, Baur-Streubel R, Bellgrove MA, Biederman J, Bralten J, Brandeis D, Brem S, ... ... Reneman L, et al. Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 33748971 DOI: 10.1111/jcpp.13396  0.622
2021 Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 46: 1-13. PMID 33735707 DOI: 10.1016/j.euroneuro.2021.02.002  0.803
2020 Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, ... ... Reneman L, et al. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. Jama Psychiatry. PMID 32857118 DOI: 10.1001/Jamapsychiatry.2020.2694  0.682
2020 Mzayek Y, de Ruiter MB, Oldenburg HSA, Reneman L, Schagen SB. Measuring decline in white matter integrity after systemic treatment for breast cancer: omitting skeletonization enhances sensitivity. Brain Imaging and Behavior. PMID 32705463 DOI: 10.1007/S11682-020-00319-1  0.759
2020 Solleveld MM, Schrantee A, Homberg JR, Lucassen PJ, Reneman L. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study. Psychiatry Research. Neuroimaging. 303: 111126. PMID 32592855 DOI: 10.1016/J.Pscychresns.2020.111126  0.74
2020 Boedhoe PSW, van Rooij D, Hoogman M, Twisk JWR, Schmaal L, Abe Y, Alonso P, Ameis SH, Anikin A, Anticevic A, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, ... ... Reneman L, et al. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. The American Journal of Psychiatry. appiajp202019030331. PMID 32539527 DOI: 10.1176/Appi.Ajp.2020.19030331  0.644
2020 Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O'Daly O, Hilal S, Wink AM, Kant I, Caan MWA, ... ... Reneman L, et al. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 117031. PMID 32526385 DOI: 10.1016/J.Neuroimage.2020.117031  0.627
2020 Schmaal L, Pozzi E, C Ho T, van Velzen LS, Veer IM, Opel N, Van Someren EJW, Han LKM, Aftanas L, Aleman A, Baune BT, Berger K, Blanken TF, Capitão L, Couvy-Duchesne B, ... ... Reneman L, et al. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Translational Psychiatry. 10: 172. PMID 32472038 DOI: 10.1038/S41398-020-0842-6  0.704
2020 Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, ... ... Reneman L, et al. Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders : Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group. Molecular Psychiatry. PMID 32467648 DOI: 10.1038/S41380-020-0774-9  0.688
2020 Han LKM, Dinga R, Hahn T, Ching CRK, Eyler LT, Aftanas L, Aghajani M, Aleman A, Baune BT, Berger K, Brak I, Filho GB, Carballedo A, Connolly CG, Couvy-Duchesne B, ... ... Reneman L, et al. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. Molecular Psychiatry. PMID 32424236 DOI: 10.1038/S41380-020-0754-0  0.714
2020 Hoogman M, van Rooij D, Klein M, Boedhoe P, Ilioska I, Li T, Patel Y, Postema MC, Zhang-James Y, Anagnostou E, Arango C, Auzias G, Banaschewski T, Bau CHD, Behrmann M, ... ... Reneman L, et al. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. Human Brain Mapping. PMID 32420680 DOI: 10.1002/Hbm.25029  0.344
2020 Walhovd KB, Amlien I, Schrantee A, Rohani DA, Groote I, Bjørnerud A, Fjell AM, Reneman L. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Ajnr. American Journal of Neuroradiology. 41: 758-765. PMID 32414901 DOI: 10.3174/Ajnr.A6560  0.663
2020 Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, Stoffelsen R, Lucassen PJ, Van Someren EJW, Rijsman RM, Reneman L. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Frontiers in Psychiatry. 11: 82. PMID 32184743 DOI: 10.3389/Fpsyt.2020.00082  0.775
2020 Schrantee A, Ruhé HG, Reneman L. Psychoradiological Biomarkers for Psychopharmaceutical Effects. Neuroimaging Clinics of North America. 30: 53-63. PMID 31759572 DOI: 10.1016/J.Nic.2019.09.006  0.611
2020 Kaiser A, Reneman L, Lucassen P, Kaag A, Van der Zwaag W, Jurhar T, Kirschbaum C, Van den Heuvel O, Hermans E, Tan H. P.192 The association between stress-induced changes in prefrontal GABA levels and heart rate variability: a 7T 1H-MRS study European Neuropsychopharmacology. 40: S111-S112. DOI: 10.1016/j.euroneuro.2020.09.147  0.762
2020 Maletic-Savatic M, Li Y, Young D, Elvsåshagen T, Loo C, Reneman L, Lucassen PJ, Calarge C, Valenzuela M. Fatty Acids as Biomarkers of Neurogenesis and New Targets for Treatment of Depression Biological Psychiatry. 87: S59. DOI: 10.1016/J.Biopsych.2020.02.174  0.474
2020 Schrantee A, Kaiser A, Lindauer R, Bottelier M, Reneman L. The Association Between Medication, Dopamine Function, and Long-Term Symptom Severity in the Matured and Developing Brain in ADHD Biological Psychiatry. 87: S18-S19. DOI: 10.1016/J.Biopsych.2020.02.073  0.787
2019 Chye Y, Mackey S, Gutman BA, Ching CRK, Batalla A, Blaine S, Brooks S, Caparelli EC, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Hutchison K, Jahanshad N, ... ... Reneman L, et al. Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study. Addiction Biology. e12830. PMID 31746534 DOI: 10.1111/Adb.12830  0.756
2019 Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology. 182528. PMID 31407970 DOI: 10.1148/Radiol.2019182528  0.814
2019 de Kovel CGF, Aftanas L, Aleman A, Alexander-Bloch AF, Baune BT, Brack I, Bülow R, Busatto Filho G, Carballedo A, Connolly CG, Cullen KR, Dannlowski U, Davey CG, Dima D, Dohm K, ... ... Reneman L, et al. No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. The American Journal of Psychiatry. appiajp201918101144. PMID 31352813 DOI: 10.1176/Appi.Ajp.2019.18101144  0.709
2019 Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ. Influence of muscarinic M receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study. Psychiatry Research. Neuroimaging. 290: 5-13. PMID 31252222 DOI: 10.1016/J.Pscychresns.2019.06.005  0.721
2019 Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, ... ... Reneman L, et al. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. The American Journal of Psychiatry. appiajp201918091033. PMID 31014101 DOI: 10.1176/Appi.Ajp.2019.18091033  0.658
2019 Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. Journal of Psychopharmacology (Oxford, England). 269881119836229. PMID 30887865 DOI: 10.1177/0269881119836229  0.748
2019 Karel P, Van der Toorn A, Vanderschuren L, Guo C, Sadighi Alvandi M, Reneman L, Dijkhuizen R, Verheij MMM, Homberg JR. Ultrahigh-resolution MRI reveals structural brain differences in serotonin transporter knockout rats after sucrose and cocaine self-administration. Addiction Biology. PMID 30748070 DOI: 10.1111/Adb.12722  0.313
2019 Kaiser A, Reneman L, Lucassen P, De Vries T, Kaag A, Schrantee A. P.3.07 Targeting emotional dysregulation in adult attention-deficit hyperactivity disorder European Neuropsychopharmacology. 29: S683-S684. DOI: 10.1016/J.Euroneuro.2019.01.069  0.778
2018 Schrantee A, Lucassen PJ, Booij J, Reneman L. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30082141 DOI: 10.1016/J.Euroneuro.2018.07.099  0.768
2018 Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Kerst JM, Kirschbaum C, Reneman L, Schagen SB. Brain hyperconnectivity >10 years after cisplatin based chemotherapy for testicular cancer. Brain Connectivity. PMID 29999422 DOI: 10.1089/Brain.2017.0569  0.773
2018 Kaag AM, Schulte MHJ, Jansen JM, van Wingen G, Homberg J, van den Brink W, Wiers RW, Schmaal L, Goudriaan AE, Reneman L. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. Drug and Alcohol Dependence. 187: 186-194. PMID 29679913 DOI: 10.1016/J.Drugalcdep.2018.03.010  0.465
2018 Kaag AM, Reneman L, Homberg J, van den Brink W, van Wingen GA. Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma. Frontiers in Psychiatry. 9: 70. PMID 29593581 DOI: 10.3389/Fpsyt.2018.00070  0.742
2018 Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB, Kooij SJJ, Reneman L. ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. Neuroimage. Clinical. 17: 53-59. PMID 29527472 DOI: 10.1016/J.Nicl.2017.09.026  0.794
2018 Karel P, Almacellas-Barbanoj A, Prijn J, Kaag AM, Reneman L, Verheij MMM, Homberg JR. Appetitive to aversive counter-conditioning as intervention to reduce reinstatement of reward-seeking behavior: the role of the serotonin transporter. Addiction Biology. PMID 29292566 DOI: 10.1111/Adb.12596  0.706
2018 Vingerhoets C, Bakker G, Pluijm Mvd, Bloemen O, Reneman L, Caan M, Booij J, Amelsvoort Tv. S172. BRAIN METABOLITES AND THE RELATION WITH COGNITION AND PSYCHOTIC SYMPTOMS IN MEDICATION-FREE PSYCHOSIS AND CONTROLS: A PHARMACOLOGICAL MAGNETIC RESONANCE SPECTROSCOPY STUDY Schizophrenia Bulletin. 44: S391-S392. DOI: 10.1016/J.Biopsych.2018.02.833  0.517
2018 Schrantee A, Wijnen JP, Solleveld MM, Nederveen AJ, Dumoulin S, Klomp DW, Reneman L, Lucassen PJ. F153. The Effect of a 12-Week Aerobic Exercise Intervention on Neurometabolites in Young Healthy Adults Using 7T Magnetic Resonance Spectroscopy Biological Psychiatry. 83: S297-S298. DOI: 10.1016/J.Biopsych.2018.02.767  0.682
2018 Schrantee A, Lucassen PJ, Reneman L, Booij J. T138. Serotonin Transporter Occupancy Predicts Default-Mode Network Connectivity: A SPECT and Resting-State fMRI Study Biological Psychiatry. 83: S182. DOI: 10.1016/J.Biopsych.2018.02.475  0.726
2017 Mugie SM, Koppen IJN, van den Berg MM, Groot PFC, Reneman L, de Ruiter MB, Benninga MA. Brain processing of rectal sensation in adolescents with functional defecation disorders and healthy controls. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. PMID 28975729 DOI: 10.1111/Nmo.13228  0.757
2017 Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Research. 269: 36-42. PMID 28938219 DOI: 10.1016/J.Pscychresns.2017.09.009  0.798
2017 Schulte MHJ, Kaag AM, Wiers RW, Schmaal L, van den Brink W, Reneman L, Homberg JR, van Wingen GA, Goudriaan AE. Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. Drug and Alcohol Dependence. 179: 117-123. PMID 28763779 DOI: 10.1016/J.Drugalcdep.2017.06.025  0.736
2017 Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage. Clinical. 15: 812-818. PMID 28725548 DOI: 10.1016/J.Nicl.2017.06.003  0.73
2017 Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28679529 DOI: 10.1096/Fj.201601234R  0.686
2017 Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. QT prolongation by dexamphetamine: Does experience matter? Journal of Cardiovascular Electrophysiology. PMID 28452189 DOI: 10.1111/Jce.13235  0.698
2017 Schrantee A, Bouziane C, Bron EE, Klein S, Bottelier MA, Kooij JJ, Rombouts SA, Reneman L. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging and Behavior. PMID 28321605 DOI: 10.1007/S11682-017-9707-X  0.81
2017 Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging and Behavior. PMID 28290072 DOI: 10.1007/S11682-017-9695-X  0.783
2017 Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. Plos One. 12: e0171724. PMID 28267750 DOI: 10.1371/Journal.Pone.0171724  0.781
2017 Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, ... ... Reneman L, et al. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. Plos One. 12: e0172776. PMID 28241065 DOI: 10.1371/Journal.Pone.0172776  0.77
2017 Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier MA, Reneman L. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage. Clinical. 13: 123-129. PMID 27942455 DOI: 10.1016/J.Nicl.2016.11.021  0.806
2017 Solleveld M, Schrantee A, Baek H, Bottelier M, Lucassen P, Van Someren E, Rijsman R, Reneman L. Enduring effects of methylphenidate on sleep in children with attention-deficit/hyperactivity disorder: a double-blind randomized controlled trial European Neuropsychopharmacology. 27: S1111-S1112. DOI: 10.1016/S0924-977X(17)31927-2  0.702
2017 Kaiser A, Schrantee A, Solleveld M, Reneman L, Lucassen P. Effects of cardiovascular fitness on hippocampal volume and vasculature in young adults European Neuropsychopharmacology. 27: S720-S721. DOI: 10.1016/S0924-977X(17)31327-5  0.765
2017 Schrantee A, Lucassen P, Booij J, Reneman L. Non-invasive magnetic resonance imaging of human serotonin function: dose-dependent effects of citalopram European Neuropsychopharmacology. 27: S707-S708. DOI: 10.1016/S0924-977X(17)31308-1  0.746
2016 Menning S, de Ruiter MB, Kieffer JM, van Rentergem JA, Veltman DJ, Fruijtier A, Oldenburg HS, Boven E, van der Meij S, Lustig V, Bos ME, Boogerd W, Reneman L, Schagen SB. Cognitive impairment in a subset of breast cancer patients following systemic therapy - results from a longitudinal study. Journal of Pain and Symptom Management. PMID 27650011 DOI: 10.1016/J.Jpainsymman.2016.04.012  0.766
2016 Kaag AM, Schluter RS, Karel P, Homberg J, van den Brink W, Reneman L, van Wingen GA. Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum. Frontiers in Human Neuroscience. 10: 418. PMID 27594829 DOI: 10.3389/Fnhum.2016.00418  0.738
2016 Vegting Y, Reneman L, Booij J. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Psychopharmacology. PMID 27568200 DOI: 10.1007/S00213-016-4396-5  0.5
2016 Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HM, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, ... ... Reneman L, et al. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27487479 DOI: 10.1001/Jamapsychiatry.2016.1572  0.795
2016 van de Vijver I, Ridderinkhof KR, Harsay H, Reneman L, Cavanagh JF, Buitenweg JI, Cohen MX. Frontostriatal anatomical connections predict age- and difficulty-related differences in reinforcement learning. Neurobiology of Aging. 46: 1-12. PMID 27460144 DOI: 10.1016/J.Neurobiolaging.2016.06.002  0.304
2016 Kaag AM, Levar N, Woutersen K, Homberg J, van den Brink W, Reneman L, van Wingen G. Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. The American Journal of Psychiatry. appiajp201615040433. PMID 27079132 DOI: 10.1176/Appi.Ajp.2016.15040433  0.735
2016 Tamminga HG, Reneman L, Huizenga HM, Geurts HM. Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis. Psychological Medicine. 1-17. PMID 27019103 DOI: 10.1017/S0033291716000350  0.35
2016 Kaag AM, van Wingen GA, Caan MW, Homberg JR, van den Brink W, Reneman L. White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances. Addiction Biology. PMID 26860848 DOI: 10.1111/Adb.12375  0.755
2016 Bottelier MA, Schrantee A, van Wingen G, Ruhé HG, de Ruiter MB, Reneman L. A power analysis for future clinical trials on the potential adverse effects of SSRIs on amygdala reactivity Frontiers in Biology. 11: 256-259. DOI: 10.1007/S11515-016-1402-6  0.645
2015 van Doorn M, Oude Rengerink K, Newsum EA, Reneman L, Majoie CB, Pajkrt E. Added value of fetal MRI in fetuses with suspected brain abnormalities on neurosonography: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-13. PMID 26592136 DOI: 10.3109/14767058.2015.1109621  0.304
2015 Stouten-Kemperman MM, de Ruiter MB, Caan MW, Boogerd W, Kerst MJ, Reneman L, Schagen SB. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping. PMID 26304182 DOI: 10.1002/Hbm.22942  0.758
2015 Klomp A, Václavů L, Meerhoff GF, Reneman L, Lucassen PJ. Correction: Effects of Chronic Fluoxetine Treatment on Neurogenesis and Tryptophan Hydroxylase Expression in Adolescent and Adult Rats. Plos One. 10: e0135876. PMID 26295703 DOI: 10.1371/journal.pone.0135876  0.706
2015 Crunelle CL, Kaag AM, van den Munkhof HE, Reneman L, Homberg JR, Sabbe B, van den Brink W, van Wingen G. Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. Human Brain Mapping. 36: 4222-30. PMID 26220024 DOI: 10.1002/Hbm.22913  0.745
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls. Brain Imaging and Behavior. PMID 26149196 DOI: 10.1007/S11682-015-9419-Z  0.721
2015 Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB. Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes. Brain Imaging and Behavior. PMID 26063438 DOI: 10.1007/S11682-015-9395-3  0.77
2015 van der Marel K, Bouet V, Meerhoff GF, Freret T, Boulouard M, Dauphin F, Klomp A, Lucassen PJ, Homberg JR, Dijkhuizen RM, Reneman L. Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis. Neuroscience. PMID 25934041 DOI: 10.1016/J.Neuroscience.2015.04.044  0.759
2015 Menning S, de Ruiter MB, Veltman DJ, Koppelmans V, Kirschbaum C, Boogerd W, Reneman L, Schagen SB. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue. Neuroimage. Clinical. 7: 547-54. PMID 25844311 DOI: 10.1016/J.Nicl.2015.02.005  0.791
2015 Bottelier MA, Schouw ML, de Ruiter MB, Ruhe HG, Lindauer RJ, Reneman L. Effects of methylphenidate during emotional processing in amphetamine users: preliminary findings. Brain Imaging and Behavior. PMID 25563230 DOI: 10.1007/S11682-014-9350-8  0.796
2015 Schrantee A, Václav? L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1172-80. PMID 25394786 DOI: 10.1038/Npp.2014.301  0.777
2015 Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, Boogerd W, Reneman L, Schagen SB. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior. 9: 275-84. PMID 24858488 DOI: 10.1007/S11682-014-9305-0  0.786
2015 Schrantee A, Mutsaerts H, Tamminga G, Bouziane C, Bottelier M, Rombouts S, Reneman L. P.1.i.044 The effects of methylphenidate on striatal dopamine system are dependent on age: a pharmacological magnetic resonance imaging study European Neuropsychopharmacology. 25: S326-S327. DOI: 10.1016/S0924-977X(15)30403-X  0.784
2015 Solleveld M, Schrantee A, Bouziane C, Ruhé H, Reneman L. P.1.i.043 Age-dependent effects of selective serotonin reuptake inhibitor exposure on the development of the GABA-ergic system European Neuropsychopharmacology. 25: S325-S326. DOI: 10.1016/S0924-977X(15)30402-8  0.768
2015 Kaag A, Levar N, Woutersen K, Homberg J, Van den Brink W, Reneman L, Van Wingen G. S.15.03 Hyperresponsiveness of the neural fear network in cocaine abuse disorder European Neuropsychopharmacology. 25: S134. DOI: 10.1016/S0924-977X(15)30078-X  0.695
2015 Koppen IJ, Mugie SM, van den Berg MM, Groot P, de Ruiter MB, Reneman L, Nederveen A, Benninga MA. Su2064 Brain Processing of Rectal Sensation in Children With Functional Defecation Disorders Gastroenterology. 148: S-588. DOI: 10.1016/S0016-5085(15)31993-4  0.31
2015 Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9419-z  0.667
2015 Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB. Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9395-3  0.726
2014 Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Veltman DJ, Reneman L, Schagen SB. Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 25529014 DOI: 10.1017/S1355617714001015  0.786
2014 Kaag AM, Crunelle CL, van Wingen G, Homberg J, van den Brink W, Reneman L. Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. Drug and Alcohol Dependence. 144: 210-7. PMID 25278147 DOI: 10.1016/J.Drugalcdep.2014.09.016  0.745
2014 Klomp A, Hamelink R, Feenstra M, Denys D, Reneman L. Increased response to a 5-HT challenge after discontinuation of chronic serotonin uptake inhibition in the adult and adolescent rat brain. Plos One. 9: e99873. PMID 24937739 DOI: 10.1371/Journal.Pone.0099873  0.697
2014 Klomp A, Václav? L, Meerhoff GF, Reneman L, Lucassen PJ. Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats. Plos One. 9: e97603. PMID 24827731 DOI: 10.1371/Journal.Pone.0097603  0.746
2014 Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. Bmc Psychiatry. 14: 48. PMID 24552282 DOI: 10.1186/1471-244X-14-48  0.789
2014 Crunelle CL, Kaag AM, van Wingen G, van den Munkhof HE, Homberg JR, Reneman L, van den Brink W. Reduced frontal brain volume in non-treatment-seeking cocaine-dependent individuals: exploring the role of impulsivity, depression, and smoking. Frontiers in Human Neuroscience. 8: 7. PMID 24478673 DOI: 10.3389/Fnhum.2014.00007  0.746
2014 van der Marel K, Klomp A, Meerhoff GF, Schipper P, Lucassen PJ, Homberg JR, Dijkhuizen RM, Reneman L. Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 263-73. PMID 23851400 DOI: 10.1038/Npp.2013.169  0.774
2014 Schrantee A, Reneman L. Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity. Neuropharmacology. 84: 159-69. PMID 23851258 DOI: 10.1016/J.Neuropharm.2013.06.029  0.649
2014 Ferguson B, Schrantee A, De Ruiter M, Bottelier M, Reneman L. P.7.e.001 Opposite effects of acute methylphenidate administration in children versus adult ADHD patients during emotional processing European Neuropsychopharmacology. 24: S728-S729. DOI: 10.1016/S0924-977X(14)71173-3  0.632
2014 Tamminga H, Reneman L, Huizenga H, Geurts H. P.7.d.012 Effects of methylphenidate on cognition in ADHD across the lifespan: preliminary results of a meta-regression analysis European Neuropsychopharmacology. 24: S727. DOI: 10.1016/S0924-977X(14)71171-X  0.36
2014 Schrantee A, Ferguson B, Stoffers D, Reneman L. P.1.i.028 Effects of dexamphetamine on fronto–striatal network connectivity in recreational users European Neuropsychopharmacology. 24: S313-S314. DOI: 10.1016/S0924-977X(14)70497-3  0.607
2014 Mugie SM, van den Berg MM, Groot P, de Ruiter MB, Reneman L, Nederveen A, Benninga MA. 242 Brain Processing of Rectal Sensation in Children With Chronic Functional Constipation Gastroenterology. 146: S-58. DOI: 10.1016/S0016-5085(14)60201-8  0.364
2013 Klomp A, van Wingen GA, de Ruiter MB, Caan MW, Denys D, Reneman L. Test-retest reliability of task-related pharmacological MRI with a single-dose oral citalopram challenge. Neuroimage. 75: 108-16. PMID 23501048 DOI: 10.1016/J.Neuroimage.2013.03.002  0.795
2013 Schouw ML, Caan MW, Geurts HM, Schmand B, Booij J, Nederveen AJ, Reneman L. Monoaminergic dysfunction in recreational users of dexamphetamine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1491-502. PMID 23415394 DOI: 10.1016/J.Euroneuro.2013.01.005  0.805
2013 Schouw ML, Kaag AM, Caan MW, Heijtel DF, Majoie CB, Nederveen AJ, Booij J, Reneman L. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI. Neuroimage. 72: 1-9. PMID 23296186 DOI: 10.1016/J.Neuroimage.2012.12.056  0.783
2013 Booij J, Reneman L, Alders M, Kuijpers TW. Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotype. American Journal of Medical Genetics. Part A. 161: 102-7. PMID 23239620 DOI: 10.1002/Ajmg.A.35687  0.572
2013 Schouw ML, De Ruiter MB, Kaag AM, van den Brink W, Lindauer RJ, Reneman L. Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. Drug and Alcohol Dependence. 130: 52-60. PMID 23142493 DOI: 10.1016/J.Drugalcdep.2012.10.010  0.796
2013 Kaag A, Crunelle C, Van den Brink W, Homberg J, Reneman L. P.6.d.005 Differential effects of short- and long-term cocaine use on cortical volume, thickness and surface area European Neuropsychopharmacology. 23: S576. DOI: 10.1016/S0924-977X(13)70917-9  0.707
2013 Schrantee A, Tremoleda J, Wylezinska-Arridge M, Gsell W, Reneman L. P.1.i.016 Amphetamine pretreatment alters the response to a methylphenidate challenge: a pharmacological magnetic resonance imaging study European Neuropsychopharmacology. 23: S272. DOI: 10.1016/S0924-977X(13)70424-3  0.624
2012 Klomp A, den Hollander B, de Bruin K, Booij J, Reneman L. The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals. Plos One. 7: e47524. PMID 23115651 DOI: 10.1371/Journal.Pone.0047524  0.749
2012 Klomp A, Caan MW, Denys D, Nederveen AJ, Reneman L. Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function. Neuroimage. 63: 1695-700. PMID 22842212 DOI: 10.1016/J.Neuroimage.2012.07.038  0.696
2012 Reneman L, de Win MM, Booij J, van den Brink W, den Heeten GJ, Freling N, Majoie CB. Incidental head and neck findings on MRI in young healthy volunteers: prevalence and clinical implications. Ajnr. American Journal of Neuroradiology. 33: 1971-4. PMID 22723061 DOI: 10.3174/Ajnr.A3217  0.715
2012 Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L. The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. Journal of Visualized Experiments : Jove. PMID 22565099 DOI: 10.3791/3956  0.792
2012 Schouw ML, Gevers S, Caan MW, Majoie CB, Booij J, Nederveen AJ, Reneman L. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 537-45. PMID 22209360 DOI: 10.1016/J.Euroneuro.2011.12.002  0.799
2012 Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L. Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology. 221: 329-39. PMID 22205158 DOI: 10.1007/S00213-011-2580-1  0.764
2012 de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Human Brain Mapping. 33: 2971-83. PMID 22095746 DOI: 10.1002/Hbm.21422  0.795
2012 Klomp A, Tremoleda JL, Wylezinska M, Nederveen AJ, Feenstra M, Gsell W, Reneman L. Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI. Neuroimage. 59: 218-26. PMID 21840402 DOI: 10.1016/J.Neuroimage.2011.07.082  0.725
2012 den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L. Preliminary evidence of hippocampal damage in chronic users of ecstasy. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 83-5. PMID 21444322 DOI: 10.1136/Jnnp.2010.228387  0.789
2011 Harsay HA, Cohen MX, Reneman L, Ridderinkhof KR. How the aging brain translates motivational incentive into action: the role of individual differences in striato-cortical white matter pathways. Developmental Cognitive Neuroscience. 1: 530-9. PMID 22436569 DOI: 10.1016/J.Dcn.2011.06.005  0.327
2011 Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P, Korte-Bouws G, van Luijtelaar G, Reneman L. Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. Plos One. 6: e16646. PMID 21304948 DOI: 10.1371/Journal.Pone.0016646  0.323
2011 de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, Boven E, Schagen SB. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping. 32: 1206-19. PMID 20669165 DOI: 10.1002/Hbm.21102  0.793
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain : a Journal of Neurology. 131: 2936-45. PMID 18842607 DOI: 10.1093/Brain/Awn255  0.742
2008 de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W. Neurotoxic effects of ecstasy on the thalamus. The British Journal of Psychiatry : the Journal of Mental Science. 193: 289-96. PMID 18827290 DOI: 10.1192/Bjp.Bp.106.035089  0.614
2008 Visser I, Lavini C, Booij J, Reneman L, Majoie C, de Boer AG, Wekking EM, de Joode EA, van der Laan G, van Dijk FJ, Schene AH, Den Heeten GJ. Cerebral impairment in chronic solvent-induced encephalopathy. Annals of Neurology. 63: 572-80. PMID 18412121 DOI: 10.1002/Ana.21364  0.667
2007 de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 458-70. PMID 17077812 DOI: 10.1038/Sj.Npp.1301225  0.742
2006 Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology (Oxford, England). 20: 389-99. PMID 16574713 DOI: 10.1177/0269881106063266  0.624
2006 de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology (Oxford, England). 20: 226-35. PMID 16510480 DOI: 10.1177/0269881106063275  0.574
2006 Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology (Oxford, England). 20: 164-75. PMID 16510475 DOI: 10.1177/0269881106061515  0.731
2005 De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research. 14: 167-85. PMID 16395871 DOI: 10.1002/Mpr.6  0.753
2005 de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 996-1005. PMID 15770240 DOI: 10.1038/Sj.Npp.1300683  0.711
2004 de Win MM, de Jeu RA, de Bruin K, Habraken JB, Reneman L, Booij J, den Heeten GJ. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 185-9. PMID 15056477 DOI: 10.1016/S0924-977X(03)00101-9  0.666
2004 de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology. 173: 376-82. PMID 14726997 DOI: 10.1007/S00213-003-1723-4  0.721
2002 Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse (New York, N.Y.). 46: 199-205. PMID 12325046 DOI: 10.1002/Syn.10130  0.67
2002 Haddad PM, Strickland P, Anderson I, Deakin JFW, Dursun SM, Ratzenböck E, Reneman L, Booij J, Den Heeten GJ, Van Den Brink W. Effects of MDMA (ecstasy) use and abstention on serotonin neurons [1] (multiple letters) Lancet. 359: 1616-1618. PMID 12047988 DOI: 10.1016/S0140-6736(02)08490-8  0.639
2002 Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Psychopharmacology. 159: 335-40. PMID 11862367 DOI: 10.1007/S00213-001-0930-0  0.721
2002 Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 387-96. PMID 11850153 DOI: 10.1016/S0893-133X(01)00366-9  0.487
2002 Reneman L, Majoie CB, Flick H, den Heeten GJ. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results. Ajnr. American Journal of Neuroradiology. 23: 231-7. PMID 11847047  0.569
2002 Reneman L, Booij J, Schmand B, Reitsma JB, De Wolff FA, Gunning WB, Den Heeten GJ, Van Den Brink W. Short- and long-term effects of ecstasy on serotonin-producing cells in the brain and on memory | Korte- en langetermijneffecten van ecstasy op serotonineproducerende hersencellen en het geheugen Nederlands Tijdschrift Voor Geneeskunde. 146: 2240-2246.  0.732
2001 Reneman L, Booij J, Majoie CB, Van Den Brink W, Den Heeten GJ. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. Human Psychopharmacology. 16: 579-588. PMID 12404537 DOI: 10.1002/Hup.347  0.732
2001 Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 358: 1864-9. PMID 11741626 DOI: 10.1016/S0140-6736(01)06888-X  0.796
2001 Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biological Psychiatry. 50: 550-4. PMID 11600108 DOI: 10.1016/S0006-3223(01)01177-5  0.591
2001 Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Archives of General Psychiatry. 58: 901-6. PMID 11576026 DOI: 10.1001/Archpsyc.58.10.901  0.72
2001 Reneman L, Majoie CB, Habraken JB, den Heeten GJ. Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology. 220: 611-7. PMID 11526257 DOI: 10.1148/Radiol.2202001602  0.596
2001 Lavalaye J, Booij J, Linszen DH, Reneman L, van Royen EA. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. Psychopharmacology. 156: 53-7. PMID 11465633 DOI: 10.1007/S002130000679  0.645
2001 Lavalaye J, Sarlet A, Booij J, Linszen DH, Reneman L, Gersons BP, van Royen EA. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology. 155: 107-9. PMID 11374328 DOI: 10.1007/S002130000670  0.647
2001 Reneman L, De Bruin K, Lavalaye J, Gunning WB, Booij J. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse (New York, N.Y.). 39: 193-200. PMID 11169768 DOI: 10.1002/1098-2396(20010301)39:3<193::Aid-Syn1000>3.0.Co;2-F  0.753
2001 Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken JB, Gersons BP, van Royen EA. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. Schizophrenia Research. 47: 59-67. PMID 11163545 DOI: 10.1016/S0920-9964(00)00023-2  0.646
2000 Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. European Journal of Nuclear Medicine. 27: 867-9. PMID 10952500 DOI: 10.1007/S002590000279  0.662
2000 Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. Ajnr. American Journal of Neuroradiology. 21: 1001-7. PMID 10871002  0.655
2000 Lavalaye J, Knol RJ, de Bruin K, Reneman L, Janssen AG, Booij J. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication. European Journal of Nuclear Medicine. 27: 346-9. PMID 10774889 DOI: 10.1007/S002590050044  0.513
2000 Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology. 148: 322-4. PMID 10755746 DOI: 10.1007/S002130050057  0.61
1999 Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. Psychiatry Research. 92: 33-44. PMID 10688158 DOI: 10.1016/S0925-4927(99)00032-3  0.64
1999 Reneman L, Booij J, Lavalaye J, De Bruin K, De Wolff FA, Koopmans RP, Stoof JC, Den Heeten GJ. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain. Synapse (New York, N.Y.). 34: 77-80. PMID 10459174 DOI: 10.1002/(Sici)1098-2396(199910)34:1<77::Aid-Syn9>3.0.Co;2-Y  0.642
1998 Booij J, Knol RJ, Reneman L, de Bruin K, Janssen AG, van Royen EA. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats. European Journal of Nuclear Medicine. 25: 1666-9. PMID 9871099 DOI: 10.1007/S002590050346  0.641
Show low-probability matches.